To qualify for weight-management treatment, patients typically need a BMI of 27 or higher, with most programs also considering weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol
The compounded semaglutide products provided by Noom are not reviewed by the FDA for safety, efficacy, or quality
Based on Phase 2 clinical trial data (Jastreboff et al., NEJM , 2023), retatrutide is administered using a gradual dose escalation schedule
If you want to explore your eligibility for GLP-1 or GIP/GLP-1 treatments today, Heally can connect you to a licensed provider who helps assess your situation and determine whether one of the approved drugs might be right for you
Now research shows it may support GLP-1 production too
Only trained personnel should work with retatrutide in controlled facilities